ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 281617 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 281617; 2) Community: the network communities that were significantly associated with the response to NSC 281617; 3) Molecule: the relationships between components within communities and NSC 281617; 4) MDR: the compounds that were significantly associated with the NSC 281617.

NSC Compound Enrichment Correlation
NSC 333054 Adriamycin, tetrahydropyranyl 0.0342636096654276 0.38268145
NSC 634724 10,11-methylenedioxycamptothecin 0.0342636096654276 0.4467797
NSC 645817 Null 0.0342636096654276 0.19995527
NSC 661746 2-Debenzoyl-2-(3',5'-difluorobenzoyl)-15(16)-anhydro-11(15->1)-abeotaxol 0.0342636096654276 0.072793497
NSC 676315 Null 0.0342636096654276 0.16956098
NSC 679743 1,4,7,10,13,16-Hexaoxacyclooctadecane-2,9-dione, 12-[4-hydroxy-3,5-bis(1,1-dimethylethyl)phenyl]- 0.0342636096654276 0.24541428
NSC 683555 Camptothecin Derivative 0.0342636096654276 0.51687939
NSC 689864 Null 0.0342636096654276 0.27240945
NSC 693324 Null 0.0342636096654276 0.35876524
NSC 693334 Null 0.0342636096654276 0.28249725
Total:50  Current:30    [First] [Prev] [Next] [Last]